Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

FDA Removes "Black Box" Warning, Exposing a Double Standard and Ushering in the Fourth Pillar of Women's Health


News provided by

Dr. Michael A. Reed, MD

Nov 12, 2025, 08:00 ET

Share this article

Share toX

Share this article

Share toX


The FDA's removal of the long-standing "black box" warning on vaginal estrogen marks a historic acknowledgment of gender disparity in medicine. Dr. Michael Reed, founder of The Cosmetic Gyn and the Institute of Restorative & Cosmetic Gynecology (IRCG), declares it the beginning of the "Fourth Pillar of Women's Health," calling for equality, evidence-based training, and restorative care

BEVERLY HILLS, Calif., Nov. 12, 2025 /PRNewswire-PRWeb/ -- In a historic move, the U.S. Food and Drug Administration has removed the decades-old "black box" warning from vaginal estrogen products. This action does more than restore prescribing freedom—it acknowledges what many in women's medicine have long known: women's sexual health has been neglected and misunderstood for decades.

For more than twenty years, the warning fueled fear, confusion, and silence. It discouraged physicians from treating even the most basic menopausal symptoms and left millions of women to suffer unnecessarily. The FDA's reversal represents not just a scientific correction but a cultural reckoning.

Women's sexual health has been abandoned for decades while men's has been celebrated. It's time to level the field--and stop apologizing for wanting to feel whole. Sexual health is not a luxury; it's a vital sign of well-being.

Post this

"This decision finally admits what medicine has quietly avoided saying," said Dr. Michael Reed, board-certified OB-GYN, certified menopause practitioner, and founder of The Cosmetic Gyn and the Institute of Restorative & Cosmetic Gynecology (IRCG).

"That women's health, especially their sexual health, has been abandoned. While men's sexual health has become a celebrated medical journey, women's has been shrouded in shame, silence, or vanity. It's time to level the field."

The Fourth Pillar of Women's Health

Dr. Reed describes this moment as the birth of a new medical frontier—the Fourth Pillar of Women's Health—joining reproductive, oncologic, and menopausal care.

This fourth pillar, Restorative and Functional Gynecology, focuses on preserving the vitality, structure, and sensation of the vulva and vagina throughout a woman's life. It merges surgical artistry with regenerative medicine to sustain comfort, function, and confidence.

"Aging of the vulva and vagina isn't just cosmetic," Dr. Reed explains. "It's a biologic process that affects tissue health, elasticity, and sensation. Just as men receive treatments to preserve testosterone, vascularity, and performance, women deserve equal access to therapies that preserve elasticity, sensation, and confidence. This isn't about vanity or youth — it's about vitality and equality.

Next Steps: From Estrogen to Comprehensive Restoration

The removal of the black box is only the first step. Experts say the next frontier must include:

  • FDA-approved testosterone for women, as already seen in Australia and the UK
  • Comprehensive physician education in menopause, regenerative and restorative gynecology
  • A shift in language—from symptom management toward proactive preservation of sexual health

"Better science demands better training," Dr. Reed said.

"Leaders like Dr. Rachel Rubin have advanced the conversation on sexual medicine. At IRCG, we're extending that work by teaching physicians to integrate surgical precision, biologic therapies, and modern recovery into a single, women-first standard."

A Call for Renewal

The removal of the black box is more than a policy change. It is a public acknowledgment that women's health has been left behind and a call to rebuild it on truth, evidence, and equality.

"This is the moment to stop apologizing for wanting to feel whole," said Dr. Reed. "For women, sexual health is not a luxury. It is a vital sign of overall well-being. The systems that ignored that truth are finally beginning to listen."

Dr. Reed invites physicians, health leaders, and women everywhere to join in defining the next era of care—one that restores confidence, function, and longevity to the most personal parts of a woman's life.

To learn more about restorative gynecology training, media opportunities, or patient resources, visit DrMichaelReed.com or follow @thecosmeticgyn on Instagram and TikTok.

About Dr. Michael Reed

Dr. Michael A. Reed, MD, a board-certified OB/GYN and one of the nation's leading authorities in functional and aesthetic gynecology, is widely known as The Cosmetic Gyn. Fellowship-trained and internationally recognized, Dr. Reed founded the Institute of Restorative & Cosmetic Gynecology (IRCG) to elevate standards of care and advance women's health globally.

He practices in Beverly Hills and Northern California.

Website: DrMichaelReed.com

Instagram and TikTok: @thecosmeticgyn

Media Contact: [email protected]

Media Contact

Dr. Michael A. Reed, MD, 1 5307532787, [email protected], www.drmichaelreed.com 

SOURCE Dr. Michael A. Reed, MD

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.